USFDA to conduct physical audit of Alembic’s Karakhadi plant
The US Food and Drug Administration (USFDA) is set to conduct a physical audit of Alembic’s Karakhadi plant in Gujarat that manufactures general injectable and ophthalmic products. The inspection is expected to begin today or tomorrow, sources told CNBC-TV18.
The US Food and Drug Administration (USFDA) is set to conduct a physical audit of Alembic’s Karakhadi plant in Gujarat that manufactures general injectable and ophthalmic products. The inspection is expected to begin today or tomorrow, sources told CNBC-TV18.
The plant will be inspected by two to three USFDA auditors, who are expected to be from India, the sources added.
This will be the first inspection of Alembic’s Karakhadi plant by USFDA.
According to the sources, the USFDA will undertake a pre-approval inspection (PAI) of certain injectables filed by the company in the US.
This is likely to be one of the first few physical audits conducted by the USFDA auditors after the COVID-19 outbreak.
Alembic is yet to respond to CNBC-TV18's queries.
Watch the video for more details
(Edited by : Niral Sharma)
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha elections: 4th phase sees over 68% voter participation, West Bengal leads with 76% turnout
May 14, 2024 1:47 AM
Lok Sabha elections phase 4 witnesses around 63% voter turnout, experts weigh in on key contests
May 14, 2024 12:06 AM
Lok Sabha Election 2024: Shiv Sena UBT’s Arvind Sawant highlights Uddhav Thackeray's vision for Mumbai’s progress
May 13, 2024 9:21 PM
Exclusive interview: 'Southern states will be a big surprise,' says PM Modi
May 13, 2024 9:05 PM